Among Veterans, women have been found to be more likely to tilt to alternative pain therapies for treating chronic pain, finds a new study. The results of this study are published in the journal of Women's Health Issues.
CIH therapies offer a non-pharmacological approach to treat chronic pain, but most of what is known about the use of these therapies come from studies of civilians, she adds. Now, Evans and colleagues at VA centers in California, the RAND Corporation, UCLA, and the Stanford School of Medicine report results of their recent study of CIH use by gender among veterans with chronic musculoskeletal pain, and variations in gender differences by race/ethnicity and age.
‘It was also found that black women veterans had significant unmet needs for pain management, which could, in turn, increase their risk for opioid and other substance use disorders.’
Evans and colleagues say U.S. military veterans being treated for chronic pain are at a heightened risk for opioid-related adverse outcomes such as accidental injuries, infectious diseases, and premature death, and women veterans may be especially affected. They found that among veterans with chronic musculoskeletal pain, more women, 36 percent, than men, 26 percent, use CIH. Rates range from 25-42 percent among women and 15-29 percent among men, depending on race/ethnicity and age.
Notably, black women are the least likely of all women veterans to use CIH therapies, irrespective of age, Evans says. "This finding suggests that black women veterans may have significant unmet needs for pain management, which could, in turn, increase their risk for opioid and other substance use disorders." Also striking was the low level of CIH use among younger white and black veterans, she adds.
For this work, the researchers conducted secondary analyses of electronic health records provided by all 79,537 women and 389,269 men veterans ages 18-54 with chronic musculoskeletal pain who received VA-provided care between 2010-13. They also examined predictors of CIH use using a race/ethnicity-by-age interaction comparison.
Overall, the authors conclude that "Women veteran patients with chronic musculoskeletal pain are more likely than men to use CIH therapies, with variation in CIH use rates by race/ethnicity and age. Tailoring CIH therapy engagement efforts to be sensitive to gender, race/ethnicity, and age could reduce differential CIH use and thereby help to diminish existing health disparities among veterans."
They add that more women veterans than men are prescribed opioids for chronic pain and women veterans are more likely to have multiple pain condition diagnoses, self-report moderate to severe pain and have co-occurring mental health problems.
For these reasons, differences in CIH therapy use are "important because they might be partially contributing to existing disparities in pain and opioid use," they point out. "Our findings suggest that VA clinicians might want to tailor their CIH engagement efforts to be sensitive to gender, race/ethnicity, and age."